Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1406238 10.3389/fphar.2024.1406238 Pharmacology Brief Research Report Interplay between metabotropic glutamate type 4 and adenosine type 1 receptors modulate synaptic transmission in the cerebellar cortex Bossi et al. 10.3389/fphar.2024.1406238 Bossi Simon * † Daniel Hervé ‡ McLean Heather * Institut des Neurosciences (NeuroPSI) UMR9197 CNRS, Université Paris-Saclay, Saclay, France

Edited by: Agenor Limon, University of Texas Medical Branch at Galveston, United States

Reviewed by: Philippe Rondard, Centre National de la Recherche Scientifique (CNRS), France

Miaomiao Mao, University of Melbourne, Australia

 *Correspondence: Simon Bossi, simon.bossi@dpag.ox.ac.uk; Heather McLean, heather.mclean@universite-paris-saclay.fr

Present address:

Simon Bossi, Centre for Cellular and Molecular Neurobiology, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom

Deceased

 15 08 2024 2024 15 1406238 24 03 2024 01 08 2024 Copyright © 2024 Bossi, Daniel and McLean. 2024 Bossi, Daniel and McLean

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

The synapses between parallel fibers and Purkinje cells play a pivotal role in cerebellar function. They are intricately governed by a variety of presynaptic receptors, notably by type 4 metabotropic glutamate (mGlu4) receptors and type 1 adenosine (A1) receptors both of which curtail glutamate release upon activation. Despite their pivotal role in regulating synaptic transmission within the cerebellar cortex, functional interactions between mGlu4 and A1 receptors have remained relatively unexplored. To bridge this gap, our study delves into how mGlu4 receptor activity influences A1 receptor-mediated alterations in excitatory transmission. Employing a combination of whole-cell patch clamp recordings of Purkinje cells and parallel fiber presynaptic fluorometric calcium measurements in acute rat and mouse cerebellar cortical slices, our results reveal functional interactions between these receptor types. These findings hold implications for understanding potential roles of these presynaptic receptors in neuroprotection during pathophysiological conditions characterized by elevated glutamate and adenosine levels.

 cerebellum mGlu4 receptor adenosine type-1 receptor interaction neurotransmission section-at-acceptance Neuropharmacology 1 Introduction

The cerebellum, long recognized for its role in motor control and learning (De Zeeuw and Ten Brinke, 2015) has more recently been linked to a wide range of cognitive and emotional functions (Schmahmann and Sherman, 1998; Sacchetti et al., 2009; Strata et al., 2011; Fastenrath et al., 2022; Ciapponi et al., 2023). At the heart of cerebellar function are the Purkinje cells (PC), the principal output neurons of the cerebellar cortex. These GABAergic neurons project primarily to the deep cerebellar nuclei and receive glutamatergic input from climbing fibers originating in the inferior olive and parallel fibers (PF) arising from cerebellar granule cells. Excess synaptic glutamate, resulting from an ischemic insult for example, can have important consequences on cerebellar function. PCs are extremely vulnerable to ischemia (Brasko et al., 1995; Ardeshiri et al., 2006) and respond to the ensuing excess extracellular glutamate by a strong anoxic depolarizing current (Hamann et al., 2005; Mohr et al., 2010). Several lines of evidence suggest that metabotropic glutamate type 4 (mGlu4) receptors play a neuroprotective role by regulating synaptic glutamate levels in pathophysiological scenarios such as epileptic seizures (Meldrum et al., 1999) or ischemic insults (Rossi et al., 2000; Panatier et al., 2004; Kalda et al., 2006; Domin et al., 2016). At the PF-PC synapse, pharmacological activation of mGlu4 receptors reversibly reduces excitatory synaptic transmission (Pekhletski et al., 1996; Lorez et al., 2003; Abitbol et al., 2008). Mechanisms underlying this phenomenon generally involve inhibition of presynaptic voltage-gated calcium channel (VGCC) activity and activation of presynaptic potassium channels, like inward rectifying K+ channels (GIRKs) (Niswender et al., 2008; Mercier and Lodge, 2014; Ribeiro et al., 2017). Consequently, action potential-evoked presynaptic calcium transients are diminished, leading to a decrease in vesicular glutamate release (Dittman and Regehr, 1996; Daniel and Crepel, 2001; Brown et al., 2003; Daniel et al., 2004; Abitbol et al., 2008). Along the same lines, extracellular adenosine, whose levels increase with hypoxic and ischemic events (Frengueilli et al., 2007; Melani et al., 2014) can have neuroprotective effects on the central nervous system through activation of presynaptic type 1 adenosine (A1) receptors (Dunwiddie and Fredholm, 1989; Dale et al., 2000; Dulla et al., 2005). Activation of these receptors can reduce excitatory synaptic transmission at central nervous system synapses for the duration of the insult (Gomes et al., 2011). This leads to an intriguing question: given the neuroprotective role attributed to mGlu4 and A1 receptors during an ischemic or hypoxic insult, are there functional interactions between these receptors, and if so, how do these interactions affect excitatory synaptic transmission at PF-PC synapses?

The cerebellar cortex provides an exemplary model for investigating the functional interplay between mGlu4 and A1 receptors, as both receptor types are expressed on granule cell PFs that innervate both PCs and molecular layer interneurons (Mateos et al., 1998; Corti et al., 2002; Wall et al., 2007; Klyuch et al., 2012; Zhang and Linden, 2012; Siddig et al., 2020). mGlu4 receptors are localized to the presynaptic active zone of PF terminals (Mateos et al., 1998; Corti et al., 2002; Siddig et al., 2020), positioned strategically to modulate action potential-driven synaptic transmission. A1 receptors are found on PF terminals (Rivkees et al., 1995; Dittman and Regehr, 1996), from which adenosine is released in an activity-dependent manner (Wall et al., 2007; Klyuch et al., 2012). Recent evidence from our laboratory has shown that in a model of simulated cerebellar ischemia, mGlu4 receptors reduce PF-PC synaptic transmission in the early stages of an excitotoxic insult (Bossi et al., 2018). Similarly, exogenous adenosine also reduces excitatory transmission at this same synapse (Kocsis et al., 1984; Blond et al., 1997).

Functional mGlu4 receptors exist exclusively as dimers (Conn and Pin, 1997) and both mGlu4 and A1 receptors can interact with other G protein-coupled receptors (GPCR), sometimes forming heterometric complexes (Nicoletti et al., 2023). To our knowledge, functional interactions between mGlu4 and A1 receptors in modulating glutamatergic synaptic transmission in the cerebellar cortex, have not been explored. We sought to address this by investigating whether mGlu4 receptor activity influences A1 receptor-mediated changes in excitatory transmission. Our approach combined whole-cell patch clamp recordings of PCs with presynaptic PF fluorometric calcium measurements in acute rat and mouse cerebellar cortical slices. Our findings suggest that there are functional interactions between these two receptor types at the PF-PC synapse, with potentially important consequences for receptor activation, function, and neuroprotection under pathophysiological conditions associated with elevated glutamate and adenosine levels.

 2 Materials and methods 2.1 Animals

Animals were housed with ad libitum access to food and water at 22°C–23°C in a standard 12 h light–dark cycle. Animal care and euthanasia procedures were in accordance with European legislation (2010/63EU Council Directive Decree) and followed Annex IV of the French Decree (1 February 2013) establishing the guidelines for euthanasia. All efforts were made to minimize animal suffering and to reduce the number of animals used in this study. Sprague Dawley rats and C57BL/6 wild-type (WT) mice came from Janvier Laboratories (France). To generate mutant mice lacking the mGlu4 receptor, Grm4+/− (B6.129-Grm4tm1Hpn/J) animals (Pekhletski et al., 1996) produced on a C57BL/6 background, were purchased from Jackson Laboratories (United States), with Charles River Laboratories (France) as the international import and distribution agent.

 2.2 Slice preparation

21 to 34–day-old male Sprague-Dawley rats, male C57BL/6 mGlu4+/+ or male mGlu4−/− mice were anesthetized with 2-bromo-2-chloro-1,1,1-trifluoroethane, then decapitated. Coronal or sagittal slices (250 µm) were cut from the cerebellar vermis in ice-cold oxygenated Bicarbonate Buffered Saline (BBS) (<1°C) with a vibratome (Microm HM 650 V). The BBS contained (in mM): NaCl, 138.6; KCl, 3; NaHCO3, 24; KH2PO4, 1.15; MgSO4, 1.15; CaCl2, 2; glucose, 10 and was gassed with 95% O2 and 5% CO2 (osmolarity, 330 mosmol/L; pH, 7.35). For electrophysiological recordings and calcium sensitive flurometric measurements, slices were transferred to a chamber on an upright microscope (Zeiss) and perfused at 2 mL per min with oxygenated BBS, supplemented with the GABAA receptor antagonist, GABAzine (5 μM). All experiments were performed at 30°C–32°C. L-AP4 (L-(+)-2-amino-4-phosphonobutyric acid) and MSOP ((RS)-α-methylserine-O-phosphate), were purchased from Tocris Bioscience, GABAzine (SR95531) from Abcam and 2-CA (2-chloroadenosine) from Sigma-Aldrich.

 2.3 Electrophysiology

Whole-cell patch-clamp recordings of PCs were performed in sagittal slices obtained from 15 Sprague-Dawley rats, 5 mGlu4 +/+ mice and 5 mGlu4 −/− mice. Recordings were made with an Axopatch-1D amplifier (Axon Instruments, United States) and PC somata were visualized using Nomarski optics and a ×63 water-immersion objective. Patch pipettes (3–3.5 MΩ) were filled the following solution (in mM): K-gluconate, 140; KCl 6; HEPES, 10; EGTA, 0.75; MgCl2, 1; Na-GTP, 0.4; Na2-ATP, 4; pH adjusted to 7.3 with KOH; 300 mosmol/L. PCs were voltage-clamped at −60 mV and junction potentials were corrected. PFs were stimulated every 6 s (0.17 Hz) through a glass saline-filled monopolar electrode placed in the molecular layer to evoke excitatory postsynaptic currents in PCs (PF-EPSCs). Recorded PF-EPSCs were filtered at 5 kHz, digitized on-line at 20 kHz, and analyzed on and off-line with Elphy (G. Sadoc, France), Igor (Wavemetrics, United States), and Clampfit (Axon Instruments, United States) software. Series resistance was partially compensated (60%–75%), as previously described by Llano et al. (1991). Recordings were terminated if this resistance increased by more than 20% of the initial value. PCs were clamped at −60 mV but PF-EPSCs were elicited on a 10 mV hyperpolarizing voltage step, which allowed monitoring of passive membrane properties (cell capacitance and membrane resistance). Cells were discarded from analysis if these parameters varied more than 20%. PF-EPSCs were evoked with pairs of stimuli of the same intensity (paired pulse stimulation), with an inter-stimulus interval of 40 ms. The paired-pulse ratio (PPR) of these responses was calculated on-line as EPSC2/EPSC1 amplitude (Atluri and Regehr, 1996).

 2.4 Calcium sensitive fluorometric measurements

Using coronal slices obtained from 6 Sprague-Dawley rats and 6 mGlu4+/+ mice, presynaptic calcium transients were recorded by photometry as previously described (Daniel and Crepel, 2001). Briefly, the membrane-permeable calcium sensitive dye Fluo4-FF-AM (100 μM, Molecular Probes) was delivered into the molecular layer of the cerebellar cortex, where PFs contact PC dendrites, using a micropipette (30 min). After allowing the fluorochrome to diffuse within the fibers, a confined window (20 × 50 µm) of labeled PFs was illuminated at a single excitation wavelength (mercury Short Arc HBO, 480 ± 22 nm) gated with an electromechanical shutter (Uniblitz, Rochester, NY, United States). Labeled PFs were stimulated every 30 s with a single train of 5 electrical stimuli (100 Hz) delivered through a saline-filled monopolar electrode. Evoked Ca2+ sensitive changes in fluorescence were acquired through a ×63 water-immersion objective of an epifluorescence microscope (Zeiss, LePeck France), with a barrier filter at 530 ± 30 nm and converted to an electric signal by a photometer (Nikon). Fluorometric measurements were analyzed on- and off-line using Elphy software. Data, corrected for dye bleaching, were expressed as relative fluorescence changes ΔF/F, where F is the baseline fluorescence intensity, and ΔF is the change induced by PF stimulation in real time. Each recording was digitalized and analyzed individually using Microsoft Excel software.

 2.5 Data statistical analysis

To analyze the effects of L-AP4 and 2-CA (alone or in the presence of MSOP) on PF–EPSCs, the amplitude of evoked currents was calculated and normalized to control values. Control amplitude and PPR was that measured before any drugs were applied. The average change in PF-EPSC amplitude and PPR associated with the L-AP4 (or 2-CA) effect was calculated over a 5-minute period at peak effect of the drug. All data are expressed as mean ± S.E.M. Statistical significance was assessed for normally distributed data using a paired or unpaired Student’s t test or analysis of variance (ANOVA) with p < 0.05 (two-tailed) considered as significant. The similarity of variances between each group of results was tested using Ficher’s test with α = 0.02. “n” indicates the number of cells included in the statistics. A p-value <0.05 was considered statistically significant.

 3 Results 3.1 Activation of presynaptic mGlu4 and A1 receptors diminishes excitatory transmission at PF-PC synapses

Before investigating functional interactions between mGlu4 and A1 receptors, we documented the effects of pharmacological activation of each of these receptor types on PF-PC evoked excitatory synaptic transmission in sagittal slices of rat cerebellar cortex. As illustrated in the inserts in Figure 1, paired pulse stimulation evoked EPSCs showcasing significant paired-pulse facilitation (PPF). PPF is a form of presynaptic short-term plasticity characteristic of synapses with low transmitter release probability (Atluri and Regehr, 1996). mGlu4 receptors were activated pharmacologically with near saturating concentrations of L-AP4 (10 μM, 5-min), a group III mGluR agonist. While L-AP4 is non-specific to all group III mGlu, mGlu4 is the only subtype functional at the PF-PC synapse and 5 min applications of L-AP4 produced maximal depressive effects (Abitbol et al., 2008). A1 receptors were activated with saturating concentrations of 2-CA (20 μM, 5-min), an adenosine analogue, commonly used as an agonist to activate these presynaptic receptors (Dittman and Regehr, 1996).

Pharmacological activation of mGlu4 and A1 receptors reduces evoked PF-EPSC amplitude in pCs in rat. (A) Normalized amplitude of the first (filled circles) and second (open triangles) PF-evoked EPSCs before, during and after 5-min applications of the group III mGluR agonist, L-AP4 (10 μM). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before (1), at the peak of the L-AP4 effect (2) and during recovery (3). The PPR, calculated as EPSC2/EPSC1 amplitude and normalized to control values, shows transient increases during L-AP4 response (n = 16). (B) Normalized amplitude of the first (filled circles) and second (open triangles) PF- evoked EPSCs before, during and after 5-min applications of the adenosine type 1 receptor agonist, 2-CA (20 μM). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before (1), at the peak of the 2-CA effect (2) and during recovery (3). Normalized values of PPR show transient increases during the 2-CA response (n = 10).

Figure 1A shows that activation of mGlu4 receptors with bath application of L-AP4 reversibly reduced the amplitude of both the first and second evoked EPSC. EPSC-1 amplitude was reduced by 44.5% ± 3.0% compared to control (pre-L-AP4) values while EPSC-2 amplitude was reduced by 37.8% ± 2.6% (n = 16, p < 0.0001). This corresponded to a significant increase in the PPR to 117% ± 7% of pre-L-AP4 values (p = 0.0279), coherent with a presynaptic locus for these mGlu4 receptors. Figure 1B shows that activation of A1 receptors also reduced evoked excitatory synaptic transmission at the PF-PC synapse. At the peak effect of 2-CA application, EPSC-1 amplitude was reduced by 61.4% ± 3.4% compared to control (pre-2-CA) values while EPSC-2 amplitude was reduced by 57.8% ± 3.4% (n = 10, p < 0.0001). The 2-CA effect was accompanied by an increase in the PPR to 115.1± 5.5% of control (pre-2-CA) values (p = 0.0222), confirming the involvement of presynaptic A1 receptors. These results affirm that pharmacological activation of mGlu4 or A1 receptors reversibly and significantly reduces excitatory synaptic transmission at the PF-PC synapse. Furthermore, the observed increases in PPR during agonist application align with a presynaptic origin for these effects. For the sake of clarity, subsequent figures illustrating electrophysiology experiments will only show data for the first EPSC (EPSC-1) and the PPR.

 3.2 Sequential activation of mGlu4 and A1 receptors partially occluded evoked presynaptic calcium transients in PF terminals

It has been reported, including by our own laboratory, that presynaptic mGlu4 and A1 receptors decrease excitatory synaptic transmission at the PC-PF synapse by diminishing calcium ion influx through presynaptic VGCCs (Dittman and Regehr, 1996; Abitbol et al., 2012). Using fluorometric measurements of evoked calcium transients in coronal sections of rat cerebellar cortex, we looked for functional interactions between mGlu4 and A1 receptor types at presynaptic PF terminals. We tested whether pharmacological activation of mGlu4 receptors occluded or reduced the effect of subsequent activation of A1 receptors, and vice versa. This experimental paradigm can indicate whether different receptor types interact functionally and/or share common signaling pathways initiating cellular responses. If mGlu4 and A1 receptors act independently at this synapse, sequential activation of these receptors would be expected to have additive effects on the amplitude of evoked calcium transients. Data were quantified as the change in evoked fluorescence (ΔF/F): first at the peak effect of the first agonist compared to control (before agonist application) and then at the peak effect of the second agonist in the presence of the first. The second agonist was applied during the peak effect of the first agonist.

As shown in Figures 2A,B, bath application of a saturating concentration of L-AP4 (100 μM, 5-min) reduced the amplitude of evoked presynaptic calcium transients by 27% ± 4.5% compared to control values (n = 5, p = 0.0038). This decrease is coherent with our previously published data in which we showed that 5 min application of 100 μM L-AP4 alone depressed evoked presynaptic calcium influx by 25.3% ± 2.3% (Abitbol et al., 2012). Subsequent application of 2-CA (10 μM, 5 min) in the presence of L-AP4 further decreased this amplitude by 13.4% ± 2.7% compared to that measured in L-AP4 alone (p = 0.0314). In a second series of experiments illustrated in Figures 2C,D, we reversed the order of agonist application (same concentrations and duration). Bath application of 2-CA reduced evoked calcium transient amplitude by 31.8% ± 2.4% (n = 4, p < 0.0001). In preliminary experiments, we found that the same application of 2-CA reversibly decreased evoked presynaptic calcium transients by 28.4% ± 4.2% (n = 8, Supplementary Figure S1). Subsequent application of L-AP4 in the presence of 2-CA further decreased this amplitude by 12.7% ± 5.1% compared to that measured in 2-CA alone (p = 0.0021). These data, represented as a stacked bar graph in Figures 2B,D, clearly show that L-AP4 and 2-CA exert more potent depressive effects on evoked PF calcium transients when applied individually than when applied sequentially. If mGlu4 and A1 receptors act independently at this synapse, one would anticipate that sequential activation of these receptors would have additive effects on the decreases in amplitude of evoked calcium transients. In other words, decreases in evoked transient amplitude in L-AP4 alone (hatched bar Figure 2B), and in the presence of 2-CA (white bar Figure 2D) would be similar. Our results hint at potential functional interactions between these two presynaptic receptors. It would have been interesting to assess the effect of sequential applications of mGlu4 and A1 receptor agonists on synaptic transmission by recording evoked EPSCs from PCs under these conditions.

Sequential activation of mGlu4 and A1 receptors show partial occlusion in reducing evoked presynaptic calcium transients in PF terminals in rat. (A) Normalized amplitude of peak fluorescence transients (ΔF/F) evoked by 5 PF stimulations (delivered at 100 Hz) before agonist application (1), during 5-min application of 100 μM L-AP4 alone (2), during 5-min application of 10 μM 2-CA in the presence of L-AP4 (3), and during recovery (4) (n = 5). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before (1), at the peak of the L-AP4 effect (2), at the peak of the 2-CA effect in L-AP4 (3) and in recovery (4). (B) The stacked bar graph shows the percent decrease of evoked fluorescence transients at maximal effect of L-AP4 alone (hatched bar) and the 2-CA effect in the presence of L-AP4 (white bar). (C) Normalized amplitude of peak fluorescence transients (ΔF/F) evoked by 5 PF stimulations (delivered at 100 Hz) before agonist application (1), during 5-min application of 10 μM 2-CA alone (2), during 5-min application of 100 μM L-AP4 in the presence of 2-CA (3), and during recovery (4) (n = 5). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before (1), at the peak of the 2-CA effect (2), at the peak of the L-AP4 effect in 2-CA (3) and in recovery (4). (D) The stacked bar graph shows the percent decrease of evoked fluorescence transients at maximal effect of 2-CA alone (hatched bar) and the L-AP4 effect in the presence of 2-CA (white bar). All plots illustrate the mean ± SEM.

 3.3 Pharmacological blockade of mGlu4 receptors enhances A1 receptor–mediated decreases in PF-PC excitatory transmission

We next explored whether blocking mGlu4 receptor activity could affect A1 receptor-mediated reductions in excitatory synaptic transmission at the PF-PC synapse. We compared the amplitude of evoked EPSCs and their PPR under two experimental conditions: bath application of 2-CA alone (20 μM, 5-min, n = 10) and in the presence of the group III mGlu receptor antagonist, MSOP (200 μM, 10-min, n = 10). As shown in Figure 3A, bath application of MSOP alone had no effect on EPSC-1 amplitude (98.3% ± 1.5% before MSOP and 101.2% ± 0.6% in MSOP, p = 0.1443), and the PPR remained unchanged (98.6% ± 0.9% before MSOP and 100.3 ± 0.4 in MSOP, p = 0.1239). In the presence of MSOP, 2-CA significantly decreased the amplitude of evoked EPSCs and concomitantly increased the PPR of PF-PC synaptic responses. However, while MSOP resulted in significantly larger 2-CA–mediated decreases in EPSC amplitude as shown in the bar graph in Figure 3B (p = 0.0185), the change in PPR with 2-CA in MSOP was not different to that obtained in 2-CA alone (p = 0.2799). Close inspection of Figure 3A reveals that in the presence of MSOP, the depressive effect of 2-CA on evoked EPSC-1 amplitude was not only larger, it also lasted longer than when 2-CA was applied alone.

Blocking mGlu4 receptors potentiates the depressive effect of A1 receptor activation on PF evoked EPSCs and presynaptic calcium transients in rat. (A) Normalized amplitude of EPSC-1 before, during and after 20 μM 2-CA applied alone (closed triangles, n = 10, same data as in Figure 1B) and in the presence of 200 μM MSOP (open triangles, n = 10). Normalized values of PPR show transient increases during 2-CA–mediated depression of evoked EPSC amplitude when administered alone (black squares) or in the presence of MSOP (white squares). (B) Percent decrease in EPSC-1 amplitude at the peak effect of 2-CA alone (filled triangles) and when applied in the presence of MSOP (open triangles). Plots are the mean ± SEM, p = 0.0185. (C) Normalized amplitudes of peak fluorescence transients (ΔF/F) evoked by 5 PF stimulations (delivered at 100 Hz) before, during and after 2-CA (20 μM) applied alone (closed circles, n = 9) and in the presence of MSOP (200 μM, open circles, n = 9). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before and at the peak of the 2-CA effect when 2-CA is applied alone (1, 2) and in the presence of MSOP (1′, 2′). (D) Percent decrease in evoked fluorescence transients at maximal 2-CA effect alone (filled circles) and in the presence of MSOP (open circles). Plots are mean ± SEM, p = 0.0287.

We confirmed these mGlu4 and A1 receptor interactions affect presynaptic calcium influx by using fluorometric measurements of evoked PF calcium transients in coronal sections of rat cerebellar cortex. Figure 3C shows that 2-CA (10 μM, 5-min) decreased evoked calcium transients and in the presence of MSOP (200 μM, 10-minutes), this effect was enhanced. In addition, the duration of the 2-CA effect was longer in the presence of MSOP. These data are quantified in the bar graph shown in Figure 3D. 2-CA alone decreased ΔF/F by 29.6% ± 1.8% compared to control values and in the presence of MSOP the average decrease rose significantly to 35.2% ± 1.5% (p = 0.0287, n = 9).

 3.4 A1 receptor–mediated decreases in PF-PC synaptic transmission are similar in mouse cerebellar cortex when mGlu4 receptors are blocked pharmacologically or deleted genetically

We then extended our results to the mouse PF-PC synapse to benefit from animals devoid of mGlu4 receptors (see Pekhletski et al., 1996). Figure 4A shows that like for rats, in wild type mice, 2-CA (10 μM, 5-min) decreased evoked EPSC amplitude and that this decrease was significantly enhanced in the presence of MSOP (200 μM, 10-min). In addition, the duration of the 2-CA effect was longer in the presence of MSOP. The effect of 2-CA on evoked EPSC amplitude was similar in both rat and wild type mouse slices (Supplementary Figure S2). Fluorometric measurements of evoked PF calcium transients in wild type mice illustrated in Figure 4B show that 2-CA alone decreased ΔF/F by 30.8% ± 2% compared to control values and in the presence of MSOP the average decrease rose significantly to 37.5% ± 1.5% (p = 0.0201, n = 10). It appears that antagonizing mGlu4 receptors enhances subsequent A1-mediated depressive effects on evoked excitatory transmission at this synapse in both rats (Figure 3) and wild type mice (Figures 4A, B), and involves presynaptic mechanisms.

Pharmacological inactivation of mGlu4 receptors potentiates the depressive effect of A1 receptor activation in mGlu4+/+ mice but not in mGlu4−/− mice. (A) Normalized amplitude of the EPSC-1 before, during and after 2-CA application (20 μM) alone (closed circles, n = 11) and in the presence of MSOP (200 μM, open circles) (n = 12) in mGlu4+/+ slices. The bar graph shows the percent decrease in EPSC-1 amplitude with 2-CA alone (filled circles) and 2-CA + MSOP (open circles). Plots are mean ± SEM, p < 0.05. (B) Normalized amplitudes of peak fluorescence transients (ΔF/F) evoked by 5 PF stimulations (delivered at 100 Hz) before, during and after 2-CA (20 μM) applied alone (closed circles, n = 9) and in the presence of MSOP (200 μM, open circles, n = 9) in mGlu4+/+ slices. Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before and at the peak of the 2-CA effect when 2-CA is applied alone (1, 2) and in the presence of MSOP (1′, 2′). The bar graph shows percent decrease in evoked fluorescence transients at maximal 2-CA effect alone (filled circles) and in the presence of MSOP (open circles). Plots are mean ± SEM, p = 0.0201. (C) Normalized amplitude of the EPSC-1 before, during and after 2-CA application (20 μM) alone in mGlu4−/− slices (closed circles, n = 11) and in the presence of MSOP (200 μM, open circles) (n = 10). Upper traces are averages of 5 consecutive evoked responses from one experiment recorded before (1), at the peak of the 2-CA effect in MSOP (2) and during recovery (3). Normalized values of PPR show transient increases during 2-CA–mediated depression of evoked EPSC amplitude when administered alone (black squares) or in the presence of MSOP (white squares). Percent decrease of EPSC-1 amplitude in mGlu4−/− slices with 2-CA alone (filled circles), in the presence of MSOP (open circles) and in mGlu4+/+ slices in the presence of MSOP (open circles, grey bar). Plots are mean ± SEM.

Finally, to further our hypothesis that mGlu4 receptor activity influences A1 receptor–mediated decreases in excitatory synaptic transmission at the PC-PF synapse, we compared the effects of A1 receptor activation in the presence of MSOP in slices obtained from wild-type mice (mGlu4+/+) with those obtained from mGlu4 knock-out mice (mGlu4−/−). As shown in Figure 4C, in mGlu4−/− slices, bath application of 2-CA alone (20 μM, 5-min) reversibly reduced EPSC-1 amplitude by 73.2% ± 2.5%. This depression resembled that observed when 2-CA was applied in the presence of MSOP (200 μM, 10-min). As expected, changes in the PPR following 2-CA application were similar in these two conditions (24.2% ± 5.9% for 2-CA in MSOP, n = 10, and 37.4% ± 4.5% for 2-CA alone in mGlu4−/− slices, n = 11, p = 0.0866). In mGlu4−/− slices, the percentage of depression in evoked EPSC-1 amplitude with 2-CA application was not different to that observed with co-application of 2-CA and MSOP (p = 0.7791). Furthermore, the depression in evoked EPSC amplitude with 2-CA applied in the presence of MSOP was similar in mGlu4−/− and mGlu4+/+ mice (p = 0.2910, n = 12). These data are summarized in the bar graph. Taken together these results indicate that inhibiting (or knocking out) presynaptic mGlu4 receptors potentiates the depressant effect of presynaptic A1 receptor activation on glutamate transmission at the PF-PC synapse thus supporting our hypothesis of functional interactions between these two receptor types at PF terminals.

 4 Discussion

Our results shed light on functional interactions between mGlu4 and A1 receptors in the cerebellar cortex. Both these receptor types, situated on PF terminals, can play a neuroprotective role by modulating glutamate release at the PF-PC synapse (Dittman and Regehr, 1996; Lorez et al., 2003; Mercier and Lodge, 2014; Bossi et al., 2018). Since it is likely that both mGlu4 and A1 are activated during pathological situations such as epileptic seizures or ischemic insults (Dunwiddie et al., 2001; Dale and Frenguelli, 2009; Melani et al., 2014), if and how the activation of one receptor type influences the other is of interest, particularly from a therapeutic perspective.

Under our experimental conditions, and in agreement with our previous studies (Abitbol et al., 2008; Abitbol et al., 2012), mGlu4 receptors do not appear to be active under “basal” physiological conditions since blocking these receptors (with MSOP) had no effect on PF evoked EPSCs or presynaptic calcium transients. However, mGlu4 receptor blockade potentiated A1 receptor–mediated decreases in both evoked PF calcium transients and excitatory transmission in both rats and wild type mice. This was not observed in mGlu4 −/− slices. Furthermore, when mGlu4 and A1 receptors were activated sequentially, the resulting decrease in evoked calcium transient amplitude was far less than the addition of the two independent depressive effects. If mGlu4 and A1 receptors act independently at this synapse, sequential activation of these receptors would be expected to have additive effects on the amplitude of evoked calcium transients. Our findings suggest possible functional interactions between these two receptor types.

What could be the nature of this interaction? While many mGluRs form heterometric complexes, dimerizing with other types of GPCRs (Lee et al., 2020; McCullock and Kammermeier, 2021; Nicoletti et al., 2023), to our knowledge, heterodimerization or even functional interactions via intracellular signaling proteins between mGlu4 and A1 receptors have not been demonstrated. Being said, different types of GPCRs may interact through β and γ subunits of G proteins. For example, Smrcka and Fisher (2019) have demonstrated that receptors coupled to Gi/o proteins may amplify the activity of receptors coupled to Gs or Gq/11 proteins because Gβγ subunits can activate certain isoforms of adenylate cyclase or phospholipase-CB binding domains. An example of this is found in Purkinje cells where the Gβγ subunits produced by the activation of the Gi-coupled GABAB receptor enhance Gq-coupled mGlu1 responses (Rives et al., 2009). These interactions have significant implications for downstream signaling pathways and the outcome of receptor activation (Nicoletti et al., 2023).

Another possible source of interaction between mGlu4 and A1 receptors could be through actors within a common or converging signaling pathway. mGlu4 receptors, like other group III mGluRs, have been repeatedly reported to be negatively coupled to the adenylate cyclase signaling pathway via pertussis toxin sensitive Gi/o proteins (Conn and Pin, 1997). While we have previously demonstrated that the vast majority of mGlu4 depressive effects on glutamate transmission at the PF-PC synapse involve the inhibition of voltage-gated calcium channels principally by way of a non-canonical, pertussis toxin insensitive intracellular cascade involving activation the PLC-PKC signalling pathway, it appears that other G-proteins, such as Gi could also be involved, albiet to a lesser extent (Abitbol et al., 2012). Indeed, proximity ligation assays show that in the molecular layer of the cerebellar cortex, mGlu4 receptors are in close proximity to both Gαq and Gαi/o proteins (Chardonnet et al., 2017). Given that A1 receptors are coupled to Gi/o proteins (Ciruela et al., 2010; Effendi et al., 2020), these two receptors may interact somewhere within the adenylate cyclase signalling pathway. However, given the small degree of mGlu4 signaling that persisted after inhibition of the PLC-PKC pathway (Abitbol et al., 2012), this probably cannot explain the significant increases in 2-CA mediated depression of presynaptic calcium transients and evoked EPSCs that we see in the present study when mGlu4 receptors are antagonized with MSOP. Future experiments with sequential or co-application of mGlu4 and A1 agonists in the presence of a protein Gq inhibitor could help resolve this question.

Finally, mGlu4 and A1 presynaptic receptors could interact independently of interactions between their G-proteins. Our previous study employing peptide affinity chromatography demonstrates that native mGlu4 receptors interact with presynaptic vesicular trafficking proteins such as Munc18-1, SNAP-25, synapsin and syntaxin (Ramos et al., 2012). Interestingly, Nakajima et al. (2009) have reported that in cultured superior cervical ganglion cells transfected with relevant mGlu4 receptor residues, mGlu4 interacts with Munc-18 to inhibit vesicular release, and this independently of protein G activation. While we know of no studies linking A1 receptors to vesicular trafficking proteins, there is evidence for interactions with heat shock (stress) proteins that, among their many roles, may also modulate ligand binding and adenosine receptor signaling (Ciruela et al., 2010). Both mGlu4 and A1 receptors can interact with other receptor types. For example, at the PF-PC synapse, mGlu4 and GABAA receptors are found on PF terminals but have opposite effects on glutamate release. Presynaptic GABAA receptors, activated by GABA spill-over, increase glutamate release from PFs (Stell et al., 2007; Pugh and Jarr, 2011) while mGlu4 activation decreases it. Using cerebellar synaptosomes, Antflick and Hampson (2012) showed that mGlu4 and GABAA receptors co-localise and interact functionally at PF terminals, but in a very surprising manner. Application of the mGlu4 agonist, L-AP4, in fact facilitates GABAA receptor–dependent release of glutamate from PF terminals. This effect was abolished when synaptosomes were treated with pertussis toxin, indicating a role for G-proteins (linked to mGlu4 receptors) in this interaction. The authors suggest that among several possible hypothesis, mGlu4 could have ligand-independent but calcium-dependent effects on vesicular trafficking proteins, as proposed by Nakajima et al. (2009). Kamibubo et al. (2013) have revealed a fascinating interplay between postsynaptic mGlu1 and A1 receptors, which closely coexist on the cell surface of Purkinje cells and have the capacity to create heteromeric complexes. In these neurons the activation of A1 receptors prompted changes in the ligand affinity of mGlu1 receptors by influencing their structural conformation thus facilitating mGlu1responses. Interestingly, in this same cell type, Tabata et al. (2007) showed inhibitory interactions between these two receptors that were independent of protein G activation. More recently Taketo (2023) demonstrated that interactions between mGlu1 and A1 receptors promote increases in intracellular calcium concentrations in hippocampal Cajal-Retzius cells with consequences on radial migration of neurons in the developing hippocampus.

What could be the significance of mGlu4-A1 receptor interactions for cerebellar function in pathological conditions associated with increases in both adenosine and glutamate in and around the synaptic space? Adenosine plays a neuroprotective role during ischemia (Melani et al., 2014), in part by activating presynaptic A1 receptors that curtail glutamate release from their terminals (Frengueilli et al., 2007; Wall et al., 2007; Gomes et al., 2011). Likewise, mGlu4 receptors also have a protective role in conditions of elevated synaptic glutamate (Lorez et al., 2003; Dale and Frenguelli, 2009; Domin et al., 2016; Domin, 2022). In a model of oxygen-glucose deprivation, we recently showed that mGlu4 receptors are activated during early stages of simulated cerebellar ischemia, thus reducing glutamate release and excitatory transmission at the PF-PC synapse (Bossi et al., 2018). How could interactions between mGlu4 and A1 receptors protect brain tissue from an ischemic insult? Ischemia begins with a loss of blood flow, and with it a deficit in oxygen delivery and fundamental metabolites such as glucose. This leads to loss in ATP synthesis, dysregulation of energy dependent processes such as the maintenance of ionic gradients, and dramatic depolarization of neurons and astrocytes, resulting in release of even more glutamate, adenosine and many other neuromodulators (Rossi et al., 2007). During the initial phases of an ischemic insult, mGlu4 receptors mitigate excitotoxicity by reducing glutamate release at their own synapse. However, if the ischemia persists, these receptors may desensitize. GPCR desensitization can arise from different events that are not mutually exclusive: receptor phosphorylation, internalization and interactions with specific regulatory proteins such as arrestins. In cultured cerebellar granule cells and transfected HEK293 cells, mGlu4 receptor-dependent cAMP inhibition is not desensitized in response to agonist stimulation (Iacovelli et al., 2004). However, when HEK293 cells co-expressed a chimeric Gαq/o protein that redirected mGlu4 coupling from adenylate cyclase to phospholipase C, these receptors indeed desensitized (Mathiesen and Ramirez, 2006). As mentioned above, PF mGlu4 receptors act mostly through a Gαq-PLC signaling pathway (Abitbol et al., 2012; Chardonnet et al., 2017). Any ensuing conformational change in mGlu4 may permit potentiation of concomitantly activated A1 receptors via intracellular protein-protein interactions, thus potentiating their modulatory effects on synaptic transmission. However, with severe ischemic insults, the neuroprotective effects of mGlu4 and A1 receptor activation will be lost in the cascade of cellular responses and may only be important during very early stages of the insult.

The interplay between type 1 adenosine and mGlu4 receptors underscores the complexity of receptor interactions. Further exploration of the mechanisms and functional implications of these interactions promises to expand our understanding of neurobiological processes, with important therapeutic potential.

 Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

 Ethics statement

The animal study was approved by Ethics committee of Paris-Saclay Institute of Neuroscience. The study was conducted in accordance with the local legislation and institutional requirements.

 Author contributions

SB: Writing–review and editing, Writing–original draft, Visualization, Validation, Software, Resources, Methodology, Investigation, Formal Analysis, Data curation, Conceptualization. HD: Writing–review and editing, Writing–original draft, Visualization, Validation, Supervision, Resources, Project administration, Methodology, Investigation, Funding acquisition, Formal Analysis, Conceptualization. HM: Writing–review and editing, Writing–original draft, Visualization, Validation, Supervision, Project administration, Methodology, Investigation, Formal Analysis, Data curation, Conceptualization.

 Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by a grant from the French National Research Organisation (ANR-07-NEURO-047-01), the Université Paris Saclay, the Centre National de la Recherche Scientifique and the Ministère de l’Education Nationale, de la Recherche et de la Technologie (doctoral scholarship to SB).

We thank Katherine Brimblecombe, Léa Le Barillier and Alexis Faure for helpful discussions and valuable comments on the manuscript.

 In memoriam

This article is dedicated to the memory of HD who passed away on 22/11/2019.

 Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2024.1406238/full#supplementary-material

Effect of Adenosine and 2-CA on evoked calcium transients in rat PF terminals. (A) Normalized amplitudes of peak fluorescence transients (ΔF/F) evoked by PF before, during and after bath application of 100 μM adenosine (n=10). (B) Normalized amplitudes of peak fluorescence transients (ΔF/F) evoked by PF before, during and after bath application of 10 μM 2-CA (n=8). (C) Percent decrease in evoked calcium transients at maximal adenosine and 2-CA effects. Bar graphs show mean ± SEM.

Effect of A1 receptor activation on evoked EPSC amplitude in rat and mGlu+/+ mice. Normalized amplitude of the EPSC-1 before, during and after 5 min 2-CA application (20 μM) alone in rat (closed circles, n = 10) and mGlu+/+ mice (open circles, n = 11) slices. Normalized values of PPR show transient increases during 2-CA – mediated depression of evoked EPSC amplitude in both rat and mouse slices. Plots are mean ± SEM. (B) The bar graph shows the percent decrease in EPSC-1 amplitude with 2-CA application in rat (filled circles) and mGlu+/+ (open circles) slices. Plots are mean ± SEM. There is no difference between these two groups.

 References Abitbol K. Acher F. Daniel H. (2008). Depression of excitatory transmission at PF‐PC synapse by group III metabotropic glutamate receptors is provided exclusively by mGluR4 in the rodent cerebellar cortex. J. Neurochem. 105 (6), 2069–2079. 10.1111/j.1471-4159.2008.05290.x Abitbol K. McLean H. Bessiron T. Daniel H. (2012). A new signalling pathway for parallel fibre presynaptic type 4 metabotropic glutamate receptors (mGluR4) in the rat cerebellar cortex. J. Physiol. 590 (13), 2977–2994. 10.1113/jphysiol.2012.232074 Antflick J. E. Hampson D. R. (2012). Modulation of glutamate release from parallel fibers by mGlu4 and pre-synaptic GABAA receptors. J. Neurochem. 120, 552–563. 10.1111/j.1471-4159.2011.07611.x Ardeshiri A. Kelly M. H. Korner I. P. Hurn P. D. Herson P. S. (2006). Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation. Eur. J. Neurosci. 24 (9), 2567–2574. 10.1111/j.1460-9568.2006.05142.x Atluri P. P. Regehr W. G. (1996). Determinants of the time course of facilitation at the granule cell to Purkinje cell synapse. J. Neurosci. 16 (18), 5661–5671. 10.1523/JNEUROSCI.16-18-05661.1996 Blond O. Daniel H. Otani S. Jaillard D. Crepel F. (1997). Presynaptic and postsynaptic effects of nitric oxide donors at synapses between parallel fibres and Purkinje cells: involvement in cerebellar long-term depression. Neuroscience 77 (4), 945–954. 10.1016/S0306-4522(96)00524-6 Bossi S. Helleringer R. Galante M. Monlleó E. Trapero A. Rovira X. (2018). A light-controlled allosteric modulator unveils a role for mGlu4 receptors during early stages of ischemia in the rodent cerebellar cortex. Front. Cell. Neurosci. 12, 449. 10.3389/fncel.2018.00449 Brasko J. Rai P. Sabol M. K. Ross D. T. (1995). The AMPA antagonist NBQX provides partial protection of rat cerebellar Purkinje cells after cardiac arrest and resuscitation. Brain Res. 669 (1), 133–138. 10.1016/0006-8993(95)01015-N Brown S. P. Brenowitz S. D. Regehr W. G. (2003). Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat. Neurosci. 6 (10), 1048–1057. 10.1038/nn1126 Chardonnet S. Bessiron T. Ramos C. I. Dammak R. Richard M. A. Boursier C. (2017). Native metabotropic glutamate receptor 4 depresses synaptic transmission through an unusual Gαq transduction pathway. Neuropharmacology 121, 247–260. 10.1016/j.neuropharm.2017.04.036 Ciapponi C. Li Y. Osorio Becerra D. A. Rodaire D. Castellato C. Mapelli L. (2023). Variations on the theme: focus on cerebellum and emotional processing. Front. Syst. Neurosci. 17, 1185752. 10.3389/fnsys.2023.1185752 Ciruela F. Albergaria C. Soriano A. Cuffí L. Carbonell L. Sánchez S. (2010). Adenosine receptors interacting proteins (ARIPs): behind the biology of adenosine signaling. Biochimica Biophysica Acta (BBA)-Biomembranes 1798 (1), 9–20. 10.1016/j.bbamem.2009.10.016 Conn P. J. Pin J. P. (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1), 205–237. 10.1146/annurev.pharmtox.37.1.205 Corti C. Aldegheri L. Somogyi P. Ferraguti F. (2002). Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110 (3), 403–420. 10.1016/S0306-4522(01)00591-7 Dale N. Frenguelli B. G. (2009). Release of adenosine and ATP during ischemia and epilepsy. Curr. Neuropharmacol. 7 (3), 160–179. 10.2174/157015909789152146 Dale N. Pearson T. Frenguelli B. G. (2000). Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. 526, 143–155. 10.1111/j.1469-7793.2000.00143.x Daniel H. Crepel F. (2001). Control of Ca2+ influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K+ channels. J. Physiology 537 (3), 793–800. 10.1111/j.1469-7793.2001.00793.x Daniel H. Rancillac A. Crepel F. (2004). Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum. J. Physiology 557 (1), 159–174. 10.1113/jphysiol.2004.063263 De Zeeuw C. I. Ten Brinke M. M. (2015). Motor learning and the cerebellum. Cold Spring Harb. Perspect. Biol. 7, a021683. 10.1101/cshperspect.a021683 Dittman J. S. Regehr W. G. (1996). Contributions of calcium-dependent and calcium-independent mechanisms to presynaptic inhibition at a cerebellar synapse. J. Neurosci. 16 (5), 1623–1633. 10.1523/JNEUROSCI.16-05-01623.1996 Domin H. (2022). Group III metabotropic glutamate receptors as promising targets for neuroprotective therapy: particular emphasis on the role of mGlu4 and mGlu7 receptors. Pharmacol. Biochem. Behav. 219, 173452. 10.1016/j.pbb.2022.173452 Domin H. Przykaza Ł. Jantas D. Kozniewska E. Boguszewski P. M. Śmiałowska M. (2016). Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: in vitro and in vivo studies. Neuropharmacology 102, 276–294. 10.1016/j.neuropharm.2015.11.025 Dulla C. G. Dobelis P. Pearson T. Frenguelli B. G. Staley K. J. Masino S. A. (2005). Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron 48 (6), 1011–1023. 10.1016/j.neuron.2005.11.009 Dunwiddie T. V. Fredholm B. B. (1989). Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. J. Pharmacol. Exp. Ther. 249 (1), 31–37. Dunwiddie T. V. Masino S. A. (2001). The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24 (1), 31–55. Effendi W. I. Nagano T. Kobayashi K. Nishimura Y. (2020). Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells 9, 785. 10.3390/cells9030785 Fastenrath M. Spalek K. Coynel D. Milnik A. Egli T. de Quervain D. J.-F. (2022). Human cerebellum and corticocerebellar connections involved in emotional memory enhancement. Proc. Natl. Acad. Sci. 119 (41), e2204900119. 10.1073/pnas.2204900119 Frengueilli B. G. Wigmore G. Llaudet E. Dale N. (2007). Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem. 101, 1400–1413. 10.1111/j.1471-4159.2006.04425.x Gomes C. V. Kaster M. P. Tomé A. R. Agostinho P. M. Cunha R. A. (2011). Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochimica Biophysica Acta (BBA)-Biomembranes 1808 (5), 1380–1399. 10.1016/j.bbamem.2010.12.001 Hamann M. Rossi D. J. Mohr C. Andrade A. L. Attwell D. (2005). The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain 128 (10), 2408–2420. 10.1093/brain/awh619 Iacovelli L. Capobianco L. Iula M. Gerevini V. D. G. Picascia A. Blahos J. (2004). Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2). Mol. Pharmacol. 65 (5), 1103–1110. 10.1124/mol.65.5.1103 Kalda A. Yu L. Oztas E. Chen J. F. (2006). Novel neuroprotection by caffeine and adenosine A2A receptor antagonists in animal models of Parkinson's disease. J. Neurological Sci. 248 (1-2), 9–15. 10.1016/j.jns.2006.05.003 Kamibubo Y. Shimomura T. Fujita Y. Tabata T. Kano M. Sakurai T. (2013). Functional cooperation of metabotropic adenosine and glutamate receptors regulates postsynaptic plasticity in the cerebellum. J. Neurosci. 33 (47), 18661–18671. 10.1523/jneurosci.5567-12.2013 Klyuch B. P. Dale N. Wall M. J. (2012). Receptor-mediated modulation of activity-dependent adenosine release in rat cerebellum. Neuropharmacology 62 (2), 815–824. 10.1016/j.neuropharm.2011.09.007 Kocsis J. D. Eng D. L. Bhisitkul R. B. (1984). Adenosine selectively blocks parallel-fiber-mediated synaptic potentials in rat cerebellar cortex. Proc. Natl. Acad. Sci. 81 (20), 6531–6534. 10.1073/pnas.81.20.6531 Lee J. Munguba H. Gutzeit V. A. Singh D. R. Kristt M. Dittman J. S. (2020). Defining the homo- and heterodimerization propensities of metabotropic glutamate receptors. Cell Rep. 31, 107605. 10.1016/j.celrep.2020.107605 Llano I. S. A. B. E. L. Marty A. Armstrong C. M. Konnerth A. (1991). Synaptic‐and agonist‐induced excitatory currents of Purkinje cells in rat cerebellar slices. J. Physiology 434 (1), 183–213. 10.1113/jphysiol.1991.sp018465 Lorez M. Humbel U. Pflimlin M. C. Kew J. N. (2003). Group III metabotropic glutamate receptors as autoreceptors in the cerebellar cortex. Br. J. Pharmacol. 138 (4), 614–625. 10.1038/sj.bjp.0705099 Mathiesen J. M. Ramirez M. T. (2009). The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation. Br. J. Pharmacol. 148 (3), 279–290. 10.1038/sj.bjp.0706733 Mateos J. M. Azkue J. Sarria R. Kuhn R. Grandes P. Knöpfel T. (1998). Localization of the mGlu4a metabotropic glutamate receptor in rat cerebellar cortex. Histochem. Cell Biol. 109, 135–139. 10.1007/s004180050211 McCullock T. M. Kammermeier P. J. (2021). The evidence for and consequences of metabotropic glutamate receptor heterodimerization. Neuropharmacology 199, 108801. 10.1016/j.neuropharm.2021.108801 Melani A. Pugliese A. M. Pedata F. (2014). Adenosine receptors in cerebral ischemia. Int. Rev. Neurobiol. 119, 309–348. 10.1016/B978-0-12-801022-8.00013-1 Meldrum B. S. Akbar M. T. Chapman A. G. (1999). Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res. 36 (2-3), 189–204. 10.1016/S0920-1211(99)00051-0 Mercier M. S. Lodge D. (2014). Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential. Neurochem. Res. 39, 1876–1894. 10.1007/s11064-014-1415-y Mohr C. Brady J. D. Rossi D. J. (2010). Young age and low temperature, but not female gender delay ATP loss and glutamate release, and protect Purkinje cells during simulated ischemia in cerebellar slices. Neuropharmacology 58 (2), 392–403. 10.1016/j.neuropharm.2009.09.013 Nakajima Y. Mochida S. Okawa K. Nakanishi S. (2009). Ca2+-dependent release of Munc18-1 from presynaptic mGluRs in short-term facilitation. Proc. Natl. Acad. Sci. 106 (43), 18385–18389. 10.1073/pnas.0910088106 Nicoletti F. Di Menna L. Iacovelli L. Orlando R. Zuena A. R. Conn P. J. (2023). GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders. Neuropharmacology 235, 109569. 10.1016/j.neuropharm.2023.109569 Niswender C. M. Johnson K. A. Weaver C. D. Jones C. K. Xiang Z. Luo Q. (2008). Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol. Pharmacol. 74 (5), 1345–1358. 10.1124/mol.108.049551 Panatier A. Poulain D. A. Oliet S. H. (2004). Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus. Neuropharmacology 47 (3), 333–341. 10.1016/j.neuropharm.2004.05.003 Pekhletski R. Gerlai R. Overstreet L. Huang X.-P. Agopyan N. Slater N. T. (1996). Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J. Neurosci. 16 (20), 6364–6373. 10.1523/JNEUROSCI.16-20-06364.1996 Pugh J. R. Jarr C. E. (2011). Axonal GABAA receptors increase cerebellar granule cell excitability and synaptic activity. J. Neurosci. 31, 565–574. 10.1523/JNEUROSCI.4506-10.2011 Ramos C. Chardonnet S. Marchand C. H. Decottignies P. Ango F. Daniel H. (2012). Native presynaptic metabotropic glutamate receptor 4 (mGluR4) interacts with exocytosis proteins in rat cerebellum. J. Biol. Chem. 287 (24), 20176–20186. 10.1074/jbc.M112.347468 Ribeiro F. M. Vieira L. B. Pires R. G. Olmo R. P. Ferguson S. S. (2017). Metabotropic glutamate receptors and neurodegenerative diseases. Pharmacol. Res. 115, 179–191. 10.1016/j.phrs.2016.11.013 Rives M. L. Vol C. Fukazawa Y. Tinel N. Trinquet E. Ayoub M. A. (2009). Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J. 28 (15), 2195–2208. 10.1038/emboj.2009.177 Rivkees S. A. Price S. L. Zhou F. C. (1995). Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677 (2), 193–203. 10.1016/0006-8993(95)00062-U Rossi D. Brady J. Mohr C. (2007). Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10, 1377–1386. 10.1038/nn2004 Rossi D. J. Oshima T. Attwell D. (2000). Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403 (6767), 316–321. 10.1038/35002090 Sacchetti B. Scelfo B. Strata P. (2009). Cerebellum and emotional behavior. Neuroscience 162 (3), 756–762. 10.1016/j.neuroscience.2009.01.064 Schmahmann J. D. Sherman J. C. (1998). The cerebellar cognitive affective syndrome. Brain 121, 561–579. 10.1093/brain/121.4.561 Siddig S. Aufmkolk S. Doose S. Jobin M. L. Werner C. Sauer M. (2020). Super-resolution imaging reveals the nanoscale organization of metabotropic glutamate receptors at presynaptic active zones. Sci. Adv. 6 (16), eaay7193. 10.1126/sciadv.aay7193 Smrcka A. V. Fisher I. (2019). G-protein βγ subunits as multi-functional scaffolds and transducers in G-protein-coupled receptor signaling. Cell. Mol. Life Sci. 76, 4447–4459. 10.1007/s00018-019-03275-2 Stell B. M. Rostaing P. Triller A. Marty A. (2007). Activation of presynaptic GABAA receptors induces glutamate release from parallel fiber synapses. J. Neurosci. 27 (34), 9022–9031. 10.1523/JNEUROSCI.1954-07.2007 Strata P. Scelfo B. Sacchetti B. (2011). Involvement of cerebellum in emotional behavior. Physiol. Res. 60 (Suppl. 1), S39–S48. 10.33549/physiolres.932169 Tabata T. Kawakami D. Hashimoto K. Kassi H. Yoshida T. Hashimotodani Y. (2007). Gprotein-independent neuromodulatory action of adenosine on metabotropic glutamate signalling in mouse cerebellar Purkinje cells. J. Physiology 581 (2), 693–708. 10.1113/jphysiol2007.129866 Taketo M. (2023). Activation of adenosine A1 receptor potentiates metabotropic glutamate receptor 1-mediated Ca2+ mobilization in the rat hippocampal marginal zone. Brain Res. 1821, 148581. 10.1016/j.brainres.2023.148581 Wall M. J. Atterbury A. Dale N. (2007). Control of basal extracellular adenosine concentration in rat cerebellum. J. Physiology 582 (1), 137–151. 10.1113/jphysiol.2007.132050 Zhang W. Linden D. J. (2012). Calcium influx measured at single presynaptic boutons of cerebellar granule cell ascending axons and parallel fibers. Cerebellum 11, 121–131. 10.1007/s12311-009-0151-3